How to Get Your Company Ready to Borrow in 2025
Here are some tips to make your loan applications go smoothly and quickly in the new year.
Read more at Inc.
Topics
-
Corporate borrowers kick off 2025 with record-setting $83bn bond bonanza
Issuers pounce on surging investor demand for debt before Donald Trump returns to the White HouseFinancial Times - 17h -
Borrowing home equity in 2025? 3 things to consider first
Borrowing home equity in 2025 could be beneficial for owners, as long as they first account for these three items.CBS News - 2d -
How to achieve your financial goals in 2025
CBS News business analyst Jill Schlesinger shares tips for saving, paying down debt and more in 2025 to help you achieve your financial goals.CBS News - 2d -
How soon can you file your 2024 income-tax return? Here’s your 2025 tax-season road map.
Tax season is just around the corner and it’s never too early to get startedMarketWatch - 2d -
Is it legal for a credit card company to sell your delinquent debt?
There are a few routes your credit card company can take when you're late on payments — including selling the debt.CBS News - 3d -
How to maximize your 401(k) plan in 2025 with higher limits, bigger catch-up contributions
If you're eager to save more for retirement, you could be overlooking ways to maximize your 401(k) plan, including key changes for 2025. Here's what to know.CNBC - 4d -
Get ready to rumble if Trump tries to eliminate the Dept. of Education
Though most Americans have little idea what the Department of Education does, there are many reasons it has withstood decades of GOP attacks.The Hill - 4d -
Scam Recruiters Are Hiring for Your Company. Here’s How to Fight Back
Employers are collateral damage in a common hiring scam. These scammers can harm prospective hires and damage your company reputation.Inc. - 5d
More from Inc.
-
Andreessen Horowitz Wants to Shoehorn AI Into Everything in 2025. Whether You Want It or Not.
Waves of hype have been unleashed on the public since ChatGPT’s unveiling in 2022. And investors have no intention of slowing down.Inc. - 2h -
Uncertainty Over Trump’s EV Policies Clouds 2025 Forecast for Carmakers
Possible tariffs and an end to a $7,500 tax credit are only two factors that could affect automakers’ plans as the new administration assumes power.Inc. - 3h -
Experts Name ‘Worst in Show’ Products at CES 2025
Some gadgets debuting at the giant trade show put your data at risk and cause waste, privacy advocates say.Inc. - 3h -
Price Stability Slowly Returns to Used Car Markets
Reduced new auto production during the pandemic cut used car supplies, too, contributing to double-digit price fluctuations and sector instability that may finally be ending.Inc. - 3h -
After $95 Million Settlement, Apple Says It Never Sold Data From Siri
The tech giant, which has a reputation for prizing user privacy, denied that its voice assistant app collected information and used it to create marketing profiles.Inc. - 4h
More in Business
-
BlackRock quits climate group in latest green climbdown
World’s largest money manager had staked out position as sustainable investment leaderFinancial Times - 26m -
Is a Macy’s near you closing? Beleaguered department store is closing 66 locations this year.
Macy’s Inc. unveils a list of more than 60 stores slated to close this year as the retailer struggles to right itself amid diminishing foot traffic at remaining stores and breathe new life into its ...MarketWatch - 31m -
Their Social Security benefits were slashed. Now they’re getting hundreds — maybe thousands — of dollars back under new law Biden just signed.
Retired public workers will get check adjustments and retro pay under the recently signed Social Security Fairness Act.MarketWatch - 40m -
My brother is squatting in a house that my siblings will eventually inherit. How do we get him out?
“We lost our dad 12 years ago and have been caring for our 82-year-old mom, who still lives independently.”MarketWatch - 44m -
Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds
AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing Medicare to negotiate prices.CNBC - 49m